BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10371421)

  • 1. Targeting of therapeutics to the liver: liposomes and viral vectors.
    Di Campli C; Wu J; Zern MA
    Alcohol Clin Exp Res; 1999 May; 23(5):950-4. PubMed ID: 10371421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted gene-delivery strategies for angiostatic cancer treatment.
    Brandwijk RJ; Griffioen AW; Thijssen VL
    Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted synthetic gene delivery vectors.
    Schaffer DV; Lauffenburger DA
    Curr Opin Mol Ther; 2000 Apr; 2(2):155-61. PubMed ID: 11249636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the strategy of using nonviral carriers in cancer gene therapy.
    Sochanik A; Szala S
    Acta Biochim Pol; 1996; 43(2):293-300. PubMed ID: 8862173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy using SV40-derived vectors: what does the future hold?
    Strayer DS
    J Cell Physiol; 1999 Dec; 181(3):375-84. PubMed ID: 10528223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking.
    Khalil IA; Kogure K; Futaki S; Harashima H
    Int J Pharm; 2008 Apr; 354(1-2):39-48. PubMed ID: 18242018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-viral gene delivery for p53.
    Pirollo KF; Xu L; Chang EH
    Curr Opin Mol Ther; 2000 Apr; 2(2):168-75. PubMed ID: 11249638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of polymeric gene delivery systems.
    Park TG; Jeong JH; Kim SW
    Adv Drug Deliv Rev; 2006 Jul; 58(4):467-86. PubMed ID: 16781003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene delivery for lung cancer using nonviral gene vectors.
    Wang JT; Peng DY; Chen M; Ye JS
    Pharmazie; 2007 Oct; 62(10):723-6. PubMed ID: 18236772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid vectors. New strategies for gene therapy].
    Romero EL; Morilla MJ; Bakas LS
    Medicina (B Aires); 2001; 61(2):205-14. PubMed ID: 11374147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SV40-based gene therapy vectors: turning an adversary into a friend.
    Strayer DS
    Curr Opin Mol Ther; 2000 Oct; 2(5):570-8. PubMed ID: 11249759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-viral ocular gene therapy: potential ocular therapeutic avenues.
    Bloquel C; Bourges JL; Touchard E; Berdugo M; BenEzra D; Behar-Cohen F
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1224-42. PubMed ID: 17095114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery.
    Li SD; Huang L
    Gene Ther; 2006 Sep; 13(18):1313-9. PubMed ID: 16953249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for targeting tumors and tumor vasculature for cancer therapy.
    Sreeramoju P; Libutti SK
    Adv Genet; 2010; 69():135-52. PubMed ID: 20807606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligonucleotide delivery to tumours using macromolecular carriers.
    Dass CR
    Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic liposomes as gene transfer vectors: barriers to successful application in gene therapy.
    Simões S; Pires P; Düzgünes N; Pedrosa de Lima MC
    Curr Opin Mol Ther; 1999 Apr; 1(2):147-57. PubMed ID: 11715939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immune response induced by gene delivery vectors.
    Sakurai H; Kawabata K; Sakurai F; Nakagawa S; Mizuguchi H
    Int J Pharm; 2008 Apr; 354(1-2):9-15. PubMed ID: 17640834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo delivery of RNAi with lipid-based nanoparticles.
    Huang L; Liu Y
    Annu Rev Biomed Eng; 2011 Aug; 13():507-30. PubMed ID: 21639780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes.
    Varga CM; Tedford NC; Thomas M; Klibanov AM; Griffith LG; Lauffenburger DA
    Gene Ther; 2005 Jul; 12(13):1023-32. PubMed ID: 15815703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.